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Background: Meningioangiomatosis (MA) is a rare meningiovascular malformation or hamartomatous lesion in the
central nervous system. Radiographic findings of MA may show a variety of characteristics according to different
histological components. We present three cases of sporadic MA with different imaging appearances in an attempt
to identify specific imaging characteristics.
Case presentation: In case 1, an irregular hyperdense solid mass was localized in the left middle cranial fossa,
demonstrating low and equal signal intensity on T1-weighted imaging (T1WI; TR/TE 2,048.9 ms/26.1 ms), high signal
intensity with multiple flow void effect on T2-weighted imaging (T2WI; TR/TE 4,000 ms/106.4 ms), and significant and
homogeneous enhancement on post-contrast magnetic resonance imaging (MRI). In case 2, the lesion in the right
insular lobe showed a cystic-mural nodule pattern. The cystic content demonstrated similar density or signal intensity as
cerebrospinal fluid, while the mural nodule demonstrated equal density or signal intensity on computed tomography
(CT) and MRI. On post-contrast MRI, the mural nodule showed significant enhancement, but the cystic wall and content
showed no enhancement. In case 3, a remarkably enhanced solid nodule was found in the cortex of the left parietal
lobe with multiple small cysts surrounding it. This nodule showed low signal intensity on T2WI and diffusion-weighted
imaging (DWI; TR/TE 6,000 ms/96.8 ms, b = 1,000 s/mm2). The preoperative diagnoses of the above three cases were
meningioma, hemangioblastoma, and ganglioglioma. However, all were pathologically diagnosed as MA.
Conclusion: The presented cases demonstrate that MA may present with solid and cystic imaging patterns, which
may include large cystic-mural nodules and small intra- and extra-cystic patterns. Although MA imaging diagnoses are
difficult, several MRI signs may include specific characteristics, such as a flow void effect on T2WI and separating cysts
in the cystic MA (as shown in our cases), gyriform hyperintensity on T2-fluid attenuated inversion recovery (FLAIR)
sequence, and susceptibility artifacts on T2 gradient echo (GRE) sequences (as found in the literature).
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Meningioangiomatosis (MA) is a rare meningiovascular
malformation or hamartomatous lesion in the central
nervous system, which was first described by Bassoe and
Nuzum [1] and then was named by Worster-Drought
et al. [2]. MA may occur sporadically or in association
with neurofibromatosis (NF) type 2. The pathological
characteristics of MA include leptomeningeal calcification* Correspondence: cjr.zhangyunting@vip.163.com
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of fibrous connective tissue. The radiographic findings of
MA may demonstrate a variety of characteristics accord-
ing to different histological components. In this study, we
present three cases of sporadic MA with different imaging
appearances and attempt to identify specific characteris-
tics to help in preoperative diagnoses. In addition, the
relevant medical literature was reviewed.
Case presentation
Case 1
A 73-year-old female patient had a history of binocular
diplopia for 1 week. Physical examination showed ais is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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computed tomography (CT) scan showed an irregular
mixed hyperdense mass in the left middle cranial fossa
(Figure 1a). On magnetic resonance imaging (MRI), the
lesion demonstrated low and equal signal intensity on
T1-weighted imaging (T1WI; TR/TE 2,048.9 ms/26.1 ms)
and high signal intensity with multiple flow void effect on
T2-weighted imaging (T2WI; TR/TE 4,000 ms/106.4 ms)
(Figure 1b,c). On post-contrast MRI, the lesion showed
significant and homogeneous enhancement after gado-
linium diethylenetriamine pentaacetate (Gd-DTPA) was
administered. The margin between the lesion and the
adjacent brain cortex was well demarcated, and there
was no obvious mass effect. The preoperative diagnosis
was meningioma.
The patient underwent a left temporal craniotomy,
and complete removal of the tumor was performed. TheFigure 1 Solid meningioangiomatosis. (a) CT scan showed an
irregular mixed high-density mass in the left middle cranial fossa.
(b) On T1WI, the lesion demonstrated low and equal signal intensity.
(c) On T2WI, the lesion showed high signal intensity with a multiple
flow void effect. (d) On post-contrast MRI, the lesion showed significant
and homogeneous enhancement. (e, f) Microphotography of specimens
showed extensive fibroblastic proliferation and an increased number of
vessels surrounded by meningothelial cells.tumor was firm, pink, and enveloped and had a general
blood supply. The base was located in the side wall of
the cavernous sinus and sphenoid crest. Microscopically,
there was extensive fibroblastic proliferation and an in-
creased number of vessels surrounded by meningothelial
cells (Figure 1e,f ). Pathological diagnosis was MA.Case 2
A 23-year-old male patient presented with left hemia-
nesthesia for more than 2 years. Physical examination
showed hypesthesia and slight ataxia on the left side,
and a decrease of graphics and two-point discrimination
sensation. A cystic-mural nodule lesion was localized in
the right insular lobe on head plain CT (Figure 2a). The
cystic portion had low density with 9 Hu, and the mural
nodule was isodense with 35 Hu. The cystic content
demonstrated similar signal intensity as cerebrospinal
fluid (CSF), while the mural nodule demonstrated iso-
signal intensity on T1WI, T2WI, and diffusion-weighted
imaging (DWI; TR/TE 6,000 ms/96.8 ms, b = 1,000 s/mm2)
(Figure 2b,c,d). On post-contrast MRI, the mural nodule
showed significant enhancement, but the cystic wall and
content demonstrated no enhancement (Figure 2e). The
adjacent brain parenchyma and sulci were compressed and
deformed, but there was no edema around the tumor. The
preoperative diagnosis was hemangioblastoma.
The patient underwent a right temporal craniotomy.
Upon operation, approximately 50 ml of a yellow trans-
parent cyst fluid was extracted from the cystic tumor.
The purple mural nodule was approximately 8 mm in
diameter with fibrous adhesion to the right insular
cortex. Pathological examination demonstrated a classic
MA appearance (Figure 2f ).Case 3
A 9-year-old girl suffered from an involuntary convul-
sion in her right limb for 1 month. Physical examination
showed no positive signs. On non-enhanced MRI, a solid
nodule 11 mm in diameter was found in the cortex of
the left parietal lobe, demonstrating low signal intensity
on DWI and T2WI (Figure 3a,b). Multiple small cysts
were around the nodule. There was a slight mass effect
and surrounding edema. After Gd-DTPA administration,
the nodule was remarkably enhanced (Figure 3c). The
preoperative diagnosis was ganglioglioma.
The patient underwent a left parietal craniotomy, and
the tumor was completely removed. The tumor was pur-
ple with an abundant blood supply, and it was unclearly
demarcated from adjacent brain tissue. Microscopically,
fibroblast-like spindle cells were arranged in spiral shape
around multiple vessels, and cortical neurons were en-
trapped within the lesion (Figure 3d). The pathological
diagnosis was MA.
Figure 2 Cystic meningioangiomatosis with a cystic-mural
nodule pattern. (a) CT scan showed a cystic-mural nodule lesion in
the right insular lobe. (b-d) In non-enhanced MRI, the cystic content
demonstrated similar signal intensity as cerebrospinal fluid (CSF), while
the mural nodule demonstrated iso-signal intensity on T1WI, T2WI,
and DWI. (e) On post-contrast MRI, the mural nodule demonstrated
significant enhancement, while the cystic wall and content showed
no enhancement. (f) Pathological examination showed perivascular
spindle-cell proliferation.
Figure 3 Cystic meningioangiomatosis with a multiple microcystic
pattern. (a, b) DWI and T2WI demonstrated a low signal intensity
nodule in the left parietal cortex and multiple small cysts surrounding
it. (c) On post-contrast MRI, the nodule was remarkably enhanced.
(d) Microscopically, fibroblast-like spindle cells were arranged in a
spiral shape around multiple vessels, and the cortical neurons were
entrapped within the lesion.
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MA can be divided into two categories: sporadic or asso-
ciated with NF type 2. Sporadic meningioangiomatosis
usually occurs in young adults or children who present
with seizures or headaches. In contrast, NF2-associated
cases are usually asymptomatic and discovered post-
mortem. MA has a slight male predominance [3], but
according to some authors [4], it has no sex predilection.
Meningioma is the most commonly associated neoplasm,
and other associated abnormalities include cerebral hemor-
rhage, oligodendroglioma, arteriovenous malformations,
cerebral softening, and meningeal hemangiopericytoma [5].
MA was mostly localized in the supratentorial region,
particularly in the temporal or frontal lobes. Sporadic
MA has mainly been reported in the temporal lobe
(33%) followed by the frontal lobe (25%), but MAaccompanied by NF has been shown to mostly occur in
the frontal lobe (35%) [6,7]. Atypical locations have also
been reported [8], including the third ventricle, thalamus,
cerebral peduncle, and brain stem. Multiple MA lesions
accompanied by NF have occurred in 35% of patients, but
the incidence of sporadic MA was only 13% [9].
The pathogenesis of MA remains unclear. Proposed
hypotheses include hamartoma with degenerative changes,
leptomeningeal meningioma with invasion in adjacent
brain tissue, and cortical vascular malformation. MA was
formerly classified as a neurocutaneous syndrome, and
some cases associated with NF supported the theory of a
hamartoma [10]. Although not all cases have a meningeal
component and malignancy characteristics are typically
absent, the association between meningioma in rare
cases and molecular aberrations regarding the NF2 gene
in both lesions suggests that MA may be correlated with
meningioma. Kim et al. [11] found that the meningioma-
tosis portions of meningiomatosis-meningioma have loss
of heterozygosity for the 22q12 locus in 28.6% (2/7) of
coexisting cases of meningiomatosis-meningioma, whereas
each pure meningiomatosis harbors one loss of hetero-
zygosity at either 22q12 or 9p21. The theory of cortical
vascular malformation corresponded to the histopatho-
logical characteristic of MA. Cortical vascular malformation
induced the perivascular meningothelial proliferation of
cells from vessel walls or pluripotent arachnoid cap cells in
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cells normally surround blood vessels as they penetrate
the cortex. Conceivably, chronic leptomeningeal stimula-
tion by underlying cortical lesions could result in MA
histopathological changes.
Histopathologically, MA has been regarded as a
hamartomatous, reactive, or neoplasic lesion originating
from multivariate cells, such as meningothelial, fibroblas-
tic, myofibroblastic, smooth muscle, or pluripotent cells
[12]. The characteristics of MA include leptomeningeal
proliferation accompanied by calcification or psammoma
body formation, perivascular cuffs of spindle-shaped
fibroblast-like cells, whorls, or bands of meningothelial
cells in association with sharply demarcated intracortical
plaques of proliferating small vessels. In our three cases,
all had the specific histological characteristics mentioned
above in the solid portion, but calcification was found only
in case 1. Other histological abnormalities included gliosis,
neuronal dysplasia, cystic degeneration of white matter,
and vascular hyalinization.
Immunohistochemical staining of MA was relatively
unhelpful for diagnosis. Positive vimentin expression
reflected the proliferation of blood vessels and perivas-
cular fibroblast-like cells in almost all cases. However,
the results of other immunohistochemical markers, such
as epithelial membrane antigen (EMA), S-100 protein,
and glial fibrillary acidic protein (GFAP), were variable
in the literature [10].
According to different percentages of perivascular cell
proliferation and cortical vascular proliferation, MA
may be broadly classified into predominantly cellular or
vascular types [13]. Predominantly cellular MA has
moderate to high cellularity such as that found in cases
2 and 3 (Figures 2f and 3d). In the central portion of
the lesion, MA cells emerge from the perivascular location
and infiltrate the cortex. Approximately 90% of reported
cases have cortical invasion, but the proliferating cells
have no significant atypia, mitoses, or necrosis. Predomin-
antly vascular MA contains thick-walled, hyalinized, and
calcified blood vessels with minimal perivascular cell
proliferation, which is observed in case 1 (Figure 1e,f).
Hemorrhage was commonly found in this subtype.
It has been observed that there are no specific MA
characteristics upon MRI or CT; thus, correct preopera-
tive MA diagnoses were difficult. MA has always been
misdiagnosed as meningioma, oligodendroglioma, gang-
lioglioma, metastasis, or arteriovenous malformation. With
regards to the location of lesions, they may manifest as
intra-axial or extra-axial lesions with well- or ill-defined
margins because of the cortex invasion. CT scans show
that lesions exhibit different densities or even normal
appearance, but calcification may be a specific indication
for MA. The probability of calcification is variable, and the
highest observed was 89.6% [14]. The signal intensity inMR images was iso- to hypointense on T1-weighted im-
ages and hypo- to hyperintense on T2-weighted images. In
case 1, multiple flow void effect could be observed within
MA on T2WI. To our knowledge, this characteristic was
first described for MA. This effect corresponded to a pre-
dominantly vascular histological type, that is, proliferating
vessels. Contrast-enhanced images also showed various
types of enhancement patterns ranging from mild to strong
and even no enhancement, but remarkable enhancement
was the most common pattern with a prevalence of 79.6%
[14]. The mass effect was none or slight. Surrounding
edema was always absent, but adjacent subcortical white
matter was occasionally hyperintense on T2WI resulting
from edema or gliosis [15].
Some specific signs on MRI may be helpful for MA
imaging diagnoses. Gyriform hyperintense on T2-fluid
attenuated inversion recovery (FLAIR) sequence has
been reported to be the most prominent characteristic
for sporadic MA on MR imaging, which can be attributed
to a thickened cortex with proliferating leptomeningeal
vessels interwoven with bands of fibrous connective tissue
[13]. Calcification may be ignored on routine T1WI and
T2WI, but it produces a susceptibility artifact on T2
gradient echo (GRE) sequences [14]. Chronic hemosiderin
from cavernous malformations also showed susceptibility
artifacts; thus, T2 GRE sequences may only be thought
of as a reference imaging modality for MA diagnoses.
Magnetic resonance spectrum (MRS) can aid in the
evaluation of brain lesions by analyzing the spectrum of
metabolites present in the area of study. Rokes et al. [16]
have reported a case of MA with a distinct choline (Cho)
peak and a decreasing N-acetyl aspartate (NAA) peak on
MRS, which suggested a proliferating tumor of presumed
non-neuronal origin. The high Cho peak could have been
a reflection of the proliferation of meningothelial cells
and/or fibroblasts that formed the concentric cuffs sur-
rounding blood vessels in the cortex. However, the high
Cho peak could have also been observed under other
conditions, for example, high-grade brain tumors [17].
We presumed that the MA imaging appearances could
be divided into two patterns: solid and cystic. Solid MA
was more common than cystic MA and demonstrated a
higher probability of calcification and remarkable enhance-
ment in most cases. Less than ten cases with cystic MA
have been reported [18-23], including cases 2 and 3,
although the total number of reported MA cases is
approximately 120. Cysts were localized within or around
solid tumors, one or multiple, and demonstrated micro-
or macrocysts. The exact mechanism underlying MA cyst
development remains controversial. Park et al. [22] specu-
lated that cysts were due to the accumulation of CSF
within lesions in a manner similar to the mechanism of
cyst formation in cystic meningiomas. Supported evidence
included cysts that were eccentric to the solid mass and
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and the subarachnoid space has not been confirmed in
MA [20]. Another potential mechanism is enlarged
perivascular spaces in which CSF gradually accumulates,
eventually resulting in the formation of cysts. In our
patient, pathologic examination demonstrated that no
tumor cells were present in the cyst wall. The cyst was
separated from the solid portion of the tumor with no
communication between the cyst and subarachnoid space.
Therefore, we assumed that enlarged perivascular space
may be a major reason for forming cystic MA.
Differential diagnoses for MA are not easy due to
variable radiological appearances. Extra-axial tumors,
such as meningiomas, are the most common differential
diagnosis. Intra-axial tumors in the superficial cortex, such
as oligodendroglioma, ganglioglioma, and dysembryoplas-
tic neuroepithelial tumor (DNET), are also frequently
considered [24]. However, for cystic MA, we thought
that differential tumors should include some cystic-mural
tumors with non-enhanced cystic walls, such as heman-
gioblastomas, pilocystic astrocytomas, and pleomorphic
xanthoastrocytomas. The MA cysts are relatively sepa-
rated from solid masses or nodule, which may be helpful
for differential diagnoses. Other non-tumor diseases, that
is, arteriovenous malformation, cavernous hemangioma,
and granuloma, are occasionally misdiagnosed as MA.
Surgical resection is important not only for seizure
control but also for pathological diagnosis. Most MAs
are completely removed without recurrence. However,
long-term seizures disappeared in only 43% of patients
after operation, and antiepileptic drug administration
was required in greater than 70% of patients [10,25].
Conclusions
The cases in this study demonstrated that MA may
present with solid or cystic imaging patterns. Imaging
diagnoses for MA were difficult due to non-specific
characteristics. Several signs on MRI may be helpful,
such as gyriform hyperintensity on T2-FLAIR sequences,
susceptibility artifacts on T2 GRE sequence, and flow
void effects on T2WI as in our case. Cysts in cystic MA
demonstrate variable appearances in location, number,
and size, but separation from solid masses or nodules
may be one of its specific characteristics.
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